|
MTDH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.229800E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.984000E-04 |
| Normal-vs-Stage2 |
7.576500E-03 |
| Normal-vs-Stage3 |
3.60890000000724E-05 |
| Normal-vs-Stage4 |
1.178760E-04 |
| Stage1-vs-Stage2 |
7.386600E-01 |
| Stage1-vs-Stage3 |
9.187600E-02 |
| Stage1-vs-Stage4 |
1.857230E-01 |
| Stage2-vs-Stage3 |
4.001400E-01 |
| Stage2-vs-Stage4 |
4.344600E-01 |
| Stage3-vs-Stage4 |
9.642800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.037260E-04 |
| Normal-vs-AfricanAmerican |
1.029430E-01 |
| Normal-vs-Asian |
1.620840E-03 |
| Caucasian-vs-AfricanAmerican |
3.007000E-01 |
| Caucasian-vs-Asian |
9.440800E-01 |
| AfricanAmerican-vs-Asian |
3.677000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.10989999999334E-06 |
| Normal-vs-Female |
4.397800E-04 |
| Male-vs-Female |
3.246200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.180300E-03 |
| Normal-vs-Age(41-60Yrs) |
3.7465999999986E-05 |
| Normal-vs-Age(61-80Yrs) |
2.207200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.816160E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.201500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.769230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.558000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.405400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.787200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.305800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.283400E-01 |
| Classical-VS-Follicular |
4.947800E-01 |
| Classical-VS-Other |
1.068020E-01 |
| Classical-VS-Normal |
1.879050E-03 |
| Tall-VS-Follicular |
5.784600E-01 |
| Tall-VS-Other |
3.153800E-01 |
| Tall-VS-Normal |
8.249500E-04 |
| Follicular-VS-Other |
2.637200E-01 |
| Follicular-VS-Normal |
1.756800E-03 |
| Other-VS-Normal |
2.584400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67370000000644E-05 |
| Normal-vs-N1 |
3.75280000000089E-05 |
| N0-vs-N1 |
2.187200E-01 |
|
|
